Show simple item record

dc.creatorMihajlović, Marija
dc.creatorNinić, Ana
dc.creatorSopić, Miron
dc.creatorMiljković, Milica
dc.creatorStefanović, Aleksandra
dc.creatorVekić, Jelena
dc.creatorSpasojević-Kalimanovska, Vesna
dc.creatorZeljković, Dejan
dc.creatorTrifunović, Bratislav
dc.creatorStjepanović, Željka
dc.creatorZeljković, Aleksandra
dc.date.accessioned2019-11-01T10:36:02Z
dc.date.available2019-11-01T10:36:02Z
dc.date.issued2019
dc.identifier.issn1878-5077
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/3458
dc.description.abstractBackground: Elevated concentrations of resistin have been reported in colorectal cancer (CRC), but its interactions with adenylate cyclase-associated protein 1 (CAP-1) are largely unexplored. We investigated resistin plasma concentration, peripheral blood mononuclear cells (PBMCs) resistin messenger ribonucleic acid (mRNA), and CAP-1 mRNA levels in CRC patients, as well as the impact of resistin gene polymorphism rs1862513 on the examined markers. We also explored associations of resistin with high-density lipoprotein cholesterol (HDL-C) and predictive potential of our parameters for CRC. Methods: Eighty-six patients with CRC and 75 healthy adults were included. Commercial ELISA kit was used for obtaining resistin’s concentrations, while polymerase chain reaction (PCR) method was applied for evaluation of resistin and CAP-1 mRNA levels and rs1862513 polymorphism. Results: Plasma resistin and CAP-1 mRNA levels were higher in CRC patients (p < 0.001 and p < 0.05, respectively), while resistin mRNA levels were lower (p < 0.001). Negative association existed among plasma resistin and HDL-C concentrations (ρ = − 0.280; p < 0.05). A model including age, body-mass index, HDL-C, low-density lipoprotein cholesterol (LDL-C), and plasma resistin concentrations as independent predictors of CRC showed very good diagnostic accuracy (AUC = 0.898). We found no associations of rs1862513 with the examined markers. Conclusions: Our study demonstrated increased plasma resistin and CAP-1 mRNA levels, implying their possible interaction in CRC. The association among plasma resistin and HDL-C might indicate that HDL-C is involved in alterations of resistin’s secretion process. As a hallmark of personalized medicine, multi-marker approach in determination of resistin-related parameters might be useful for prediction and prevention of CRC development.en
dc.language.isoensr
dc.publisherSpringersr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175035/RS//sr
dc.rightsrestrictedAccesssr
dc.sourceEPMA Journalsr
dc.subjectAdenylate cyclase-associated protein 1sr
dc.subjectColorectal cancersr
dc.subjectHigh-density lipoprotein cholesterolsr
dc.subjectParaoxonase-1 activitysr
dc.subjectPredictive preventive personalized medicinesr
dc.subjectResistinsr
dc.titleAssociation among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicineen
dc.typearticlesr
dc.rights.licenseARRsr
dcterms.abstractЗељковић, Aлександра; Нинић, Aна; Сопић, Мирон; Михајловић, Марија; Миљковић, Милица; Стефановић, Aлександра; Векић, Јелена; Спасојевић-Калимановска, Весна; Зељковић, Дејан; Трифуновић, Братислав; Стјепановић, Жељка;
dc.citation.volume10
dc.citation.spage307
dc.citation.epage316
dc.citation.rankM21
dc.identifier.wos000489790500009
dc.identifier.doi10.1007/s13167-019-00178-x
dc.identifier.scopus2-s2.0-85069475188
dc.type.versionpublishedVersionsr


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record